SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001069530-22-000025
Filing Date
2022-05-09
Accepted
2022-05-09 16:52:18
Documents
12
Period of Report
2022-05-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K sava-20220505x8k.htm   iXBRL 8-K 131584
  Complete submission text file 0001069530-22-000025.txt   254242

Data Files

Seq Description Document Type Size
2 EX-101.SCH sava-20220505.xsd EX-101.SCH 2686
3 EX-101.LAB sava-20220505_lab.xml EX-101.LAB 15330
4 EX-101.PRE sava-20220505_pre.xml EX-101.PRE 10935
6 EXTRACTED XBRL INSTANCE DOCUMENT sava-20220505x8k_htm.xml XML 4769
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29959 | Film No.: 22905871
SIC: 2834 Pharmaceutical Preparations